Expertise in
13
conditions

Daniele Cattaneo

Milan, IT 
Expertise in
13
conditions
Milan, IT 

Overview

Daniele Cattaneo practices practicing medicine in Milan, Italy.

Ms. Cattaneo is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Chronic Myelogenous Leukemia (CML), and Essential Thrombocythemia.

She is actively involved in clinical research, co-authoring 148 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Milan, Italy
Other Locations
Ca' Granda, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

The Benefit/Risk Profile of Pegylated Proline-Interferon Alpha-2b (AOP2014) Added to the Best Available Strategy Based on Phlebotomies in Low-risk Patients With Polycythemia Vera (PV). The Low-PV Randomized Trial
The Benefit/Risk Profile of Pegylated Proline-Interferon Alpha-2b (AOP2014) Added to the Best Available Strategy Based on Phlebotomies in Low-risk Patients With Polycythemia Vera (PV). The Low-PV Randomized Trial
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Procedure
Study Drugs: AOP2014, Acetylsalicylic acid
Study Phase: Phase 2
Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
Secondary Cancers in Myeloproliferative Neoplasms (MPN-K Study)
Enrollment Status: Completed
Publish Date: December 06, 2019
Intervention Type: Other
An International Field Study for the Reliability and Validity of the Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia (EORTC QLQ-CML24)
An International Field Study for the Reliability and Validity of the Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia (EORTC QLQ-CML24)
Enrollment Status: Unknown
Publish Date: March 21, 2019
View 2 Less Clinical Trials

148 Total Publications

Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.
Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.
Journal: Blood advances
Published: May 18, 2026

Frequently Asked Questions about Daniele Cattaneo

Is Daniele Cattaneo a top-rated expert for Myelofibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Daniele Cattaneo is classified as an Elite expert for Myelofibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Daniele Cattaneo participate in research or clinical trials?

Yes. Daniele Cattaneo has published 148 articles and abstracts on conditions like Myelofibrosis. You can view a list of Daniele Cattaneo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Cattaneo's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 20 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile